Related Experiment Videos

[Adverse effects of parenteral administration of antisense oligonucleotides]

A Białek1, M Kawalec, G Hoser

  • 1Klinika Gastroenterologii Instytutu Chorób Wewnetrznych Pomorskiej Akademii Medycznej w Szczecinie.

Insights

Phosphorothioate antisense oligodeoxynucleotides ([S]ODNs) showed mild, temporary toxicity in mice, primarily affecting the spleen, liver, and kidneys. These effects were linked to [S]ODN accumulation in specific organs.

Area of Science:

  • Pharmacology
  • Toxicology
  • Oligonucleotide Therapeutics

Context:

  • Antisense oligodeoxynucleotides (ODNs) are a promising therapeutic modality.
  • Phosphorothioate modification ([S]ODN) enhances stability but can induce toxicity.
  • Understanding in vivo toxicity is crucial for clinical translation.

Purpose:

  • To characterize the in vivo toxicity profile of 26-mer bcr-abl antisense oligodeoxynucleotides ([S]ODNs).
  • To evaluate the effects of [S]ODN treatment on various organs and blood parameters in mice.

Summary:

  • Mice received daily intravenous [S]ODN injections for 9 days.
  • Blood analysis revealed altered levels of liver enzymes, proteins, glucose, and blood urea nitrogen.
  • Histopathological examination showed splenomegaly, reactive hepatitis, and renal atrocytosis in treated mice.
  • Observed effects included mild anemia and thrombocytopenia.

Impact:

  • The study demonstrates that [S]ODNs exhibit limited and transient toxicity.
  • Toxicity is primarily localized to organs known for [S]ODN accumulation.
  • Findings support the potential therapeutic use of [S]ODNs with careful monitoring.

Related Concept Videos